• Royal Bank of Canada Cuts Sage Therapeutics (NASDAQ:SAGE) Price Target to $15.00

    Source: Buzz FX / 27 Apr 2024 08:41:27   America/Chicago


    Sage Therapeutics ( NASDAQ:SAGE – Free Report) had its target price lowered by Royal Bank of Canada from $26.00 to $15.00 in a report issued on Friday, Benzinga reports. The firm currently has a sector perform rating on the biopharmaceutica
    Read more...
Share on,